...
首页> 外文期刊>Patient Preference and Adherence >Quality of life assessment in patients with alopecia areata and androgenetic alopecia in the People’s Republic of China
【24h】

Quality of life assessment in patients with alopecia areata and androgenetic alopecia in the People’s Republic of China

机译:中华人民共和国斑秃和雄激素性脱发患者的生活质量评估

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Introduction: In medical terms, alopecia is considered a relatively mild dermatological condition that nevertheless is a serious condition, but it causes major depression in many sufferers. Alopecia areata (AA) and androgenetic alopecia (AGA) are the main types of hair loss. This study assessed the quality of life (QoL) of Chinese patients with AA and AGA using the Dermatology Life Quality Index (DLQI) questionnaire. Methods: A total of 178 AA and AGA patients were enrolled in this study, and DLQI was used to evaluate the QoL of the patients. The DLQI used 10 items regarding symptoms and feelings, daily activities, leisure, work and school, personal relationships, and treatment as dimensions of life. Each was scored on a 0–3 scale. The total DLQI score equaled 0–30; higher scores showed greater impact on QoL. Results: The DLQI scores of the 178 patients ranged from 0 to 28, with a mean score of 6.3. Higher DLQI scores were reported by younger patients ( P 12 months ( P 12 months, and AA. Both AA and AGA moderately affected the QoL of the patients not only in physiological aspects but also in their emotional and social aspects. The bio-psycho-social aspects of disease need to be addressed in patients with AA and AGA, even though these conditions are not life-threatening.
机译:简介:从医学角度讲,脱发被认为是一种相对轻度的皮肤病,尽管它是一种严重的疾病,但它却导致许多患者严重抑郁。斑秃(AA)和雄激素性脱发(AGA)是脱发的主要类型。这项研究使用皮肤病生活质量指数(DLQI)问卷评估了中国AA和AGA患者的生活质量(QoL)。方法:本研究共纳入178位AA和AGA患者,并使用DLQI评估患者的QoL。 DLQI使用了10项关于症状和感觉,日常活动,休闲,工作和学校,人际关系和治疗作为生活维度的项目。每个人的得分为0-3。 DLQI总分等于0–30;分数越高,对生活质量的影响越大。结果:178例患者的DLQI评分范围为0至28,平均评分为6.3。年轻的患者(P 12个月(P 12个月,以及AA)报告了更高的DLQI评分。AA和AGA不仅在生理方面而且在他们的情感和社交方面都对患者的QoL有中等程度的影响。尽管AA和AGA患者的病情并不危及生命,但仍需要解决其疾病的社会问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号